Montelukast Prescribing at MODALITY PARTNERSHIP (AWC)
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
9,079
Total Quantity
276.6K
NHS Cost
£14.8K
vs National Avg
+1225.9%
MODALITY PARTNERSHIP (AWC) prescribed 9,079 items of Montelukast over the last 12 months at a cost of £14,798 to the NHS. This is 1225.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
783
Jun 2026
742
Jun 2026
795
Jun 2026
720
Jun 2026
808
Jun 2026
788
Jun 2026
760
Jun 2026
748
Jun 2026
787
Jun 2026
692
Jun 2026
723
Jun 2026
733
Prescribing Details
| Total Items | 9,079 |
|---|---|
| Total Quantity | 276,647 |
| Total NHS Cost | £14,798 |
| Presentations | 6 different forms |
| vs National Average | +1225.9% |
Montelukast Prescribing Comparison
| This practice | 9,079 items |
|---|---|
| National average per practice | 685 items |
| Difference | +1225.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.